Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer

Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer

Background/Aims: Interleukin (IL)-35 has immunosuppressive functions in autoimmune diseases, infectious diseases, and certain cancers. However, few studies have focused on its immunoregulatory activity in non-small cell lung cancer (NSCLC). Thus, we investigated the role of IL-35 in the pathogenesis...

Full description

Bibliographic Details
Main Authors:	Hong-Min Wang, Xiao-Hong Zhang, Ming-Ming Feng, Yan-Jun Qiao, Li-Qun Ye, Jing Chen, Fei-Fei Fan, Lin-Lin Guo
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2018-07-01
Series:	Cellular Physiology and Biochemistry
Subjects:	Non-small cell lung cancer Interleukin-35 T cells Antitumor activity Immunoregulation
Online Access:	https://www.karger.com/Article/FullText/491615

Similar Items

Interleukin-35 on B cell and T cell induction and regulation
by: Ai Huang, et al.
Published: (2017-08-01)

Interleukin-35 Expression in Non-Small Cell Lung Cancer is Associated with Tumor Progression
by: Mingfei Sun, et al.
Published: (2018-11-01)

Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells
by: Xing-Feng Zheng, et al.
Published: (2018-08-01)

Interleukin-35 Suppresses Interleukin-9-Secreting CD4+ T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma
by: Qian Zhang, et al.
Published: (2021-06-01)

Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious Tolerance
by: Brian M Olson, et al.
Published: (2013-10-01)

Decreased Circulating Interleukin-35 Levels Are Related to Interleukin-4-Producing CD8+ T Cells in Patients with Allergic Asthma
by: Wei Wang, et al.
Published: (2015-10-01)

Interleukin-35 in Iraqi's Menopausal Women with Osteoporosis
by: Husam S. Jasim
Published: (2017-03-01)

Interleukin 35: protective role and mechanism in type 1 diabetes
by: Si-Ming Zhang, et al.
Published: (2023-02-01)

Interleukin 35 induced Th2 and Tregs bias under normal conditions in mice
by: Xiaoning Zhang, et al.
Published: (2018-09-01)

The algal polysaccharide ulvan suppresses growth of hepatoma cells
by: Chao Zhao, et al.
Published: (2020-03-01)

CD19+CD24highCD27+ B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients
by: Hui Xiong, et al.
Published: (2022-12-01)

Administration of Interleukin-35-Conditioned Autologous Tolerogenic Dendritic Cells Prolong Allograft Survival After Heart Transplantation
by: Xianglan Liu, et al.
Published: (2018-09-01)

Increased Interleukin-35 suppresses peripheral CD14+ monocytes function in patients with Kawasaki disease
by: Haijian Xing, et al.
Published: (2020-04-01)

Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis
by: Siqi Liu, et al.
Published: (2023-03-01)

Interleukin-24 Regulates T Cell Activity in Patients With Colorectal Adenocarcinoma
by: Yang Zhang, et al.
Published: (2019-12-01)

Interleukin‐36α suppresses growth of non‐small cell lung cancer in vitro by reducing angiogenesis
by: Xiaoxiao Xie, et al.
Published: (2021-05-01)

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis
by: Hui Zhang, et al.
Published: (2021-04-01)

The diagnostic value of interleukin 35 as a septic biomarker: A meta-analysis
by: Yuanhui Hu, et al.
Published: (2022-11-01)

Interleukin-35 pathobiology in periodontal disease: a systematic scoping review
by: Patrick R. Schmidlin, et al.
Published: (2021-03-01)

Estimating the salivary levels of IL-35 in smokers with periodontitis: A cross sectional study
by: P. Yuvashri, et al.
Published: (2024-01-01)

Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity
by: Rosmely Hernandez, et al.
Published: (2022-05-01)

Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells
by: Min Lian, et al.
Published: (2019-11-01)

Effect of interleukin (IL)-35 on IL-17 expression and production by human CD4+ T cells
by: Kosuke Okada, et al.
Published: (2017-02-01)

Interleukin-35 in autoimmune dermatoses: Current concepts
by: Xie Yuming, et al.
Published: (2022-03-01)

Interleukin-4 Supports the Suppressive Immune Responses Elicited by Regulatory T Cells
by: Wei-Cheng Yang, et al.
Published: (2017-11-01)

Effect of IL-35 on the adhesion of human umbilical vein endothelial cells after sCD40L stimulation
by: GUO Weiwei, ZHAO Pingping, YU Lulu, LI Ming
Published: (2023-03-01)

Expression of interleukin-35 and type 2 cytokines in children with acute allergic asthma
by: Zhangqiao Cai, et al.
Published: (2021-09-01)

Comparative Biochemical Study of Interleukin -35 and Some Sex Hormones in MS Female Patients with Duration of the Disease*
by: Ali K. Baden, et al.
Published: (2017-04-01)

Mechanism of TCF21 Downregulation Leading to Immunosuppression of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer
by: Hong Liu, et al.
Published: (2023-09-01)

Association of Interleukin-32α with Interleukin-35 and Transforming Growth Factor-β Produced by the Peripheral Blood Mononuclear Cells from Patients with Type 2 Diabetes Mellitus
by: Vida Sheikh, et al.
Published: (2023-06-01)

Interleukin-1 in the Response of Follicular Helper and Follicular Regulatory T Cells
by: Paul-Gydéon Ritvo, et al.
Published: (2019-02-01)

Regulatory B Cells Dysregulated T Cell Function in an IL-35-Dependent Way in Patients With Chronic Hepatitis B
by: YaYun Liu, et al.
Published: (2021-04-01)

Effect of IL-35 on soluble CD40 ligand-induced injury of vascular endothelial cells
by: LI Ming, SUN Hai-ling, LIU Juan-li, GUO Wei-wei
Published: (2022-11-01)

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
by: Diana Llopiz, et al.
Published: (2018-09-01)

Serum levels of interleukin-23 and 35 in patients with and without type 2 diabetes mellitus and chronic periodontitis
by: Avideh Maboudi, et al.
Published: (2019-06-01)

Current Insight into the Role of IL-35 and Its Potential Involvement in the Pathogenesis and Therapy of Atopic Dermatitis
by: Weronika Zysk, et al.
Published: (2022-12-01)

Current Research of the Roles of IL-35 in Tumor Progression
by: Chongbiao HUANG, et al.
Published: (2016-04-01)

Effect of nonsurgical periodontal therapy on interleukin-35 level in gingival crevicular fluid
by: Ashwini Jadhav, et al.
Published: (2023-01-01)

Impaired Regulation by IL-35 in Systemic Sclerosis
by: Rubén Osuna-Gómez, et al.
Published: (2023-06-01)

Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
by: Zhengkang Luo, et al.
Published: (2021-11-01)